新莱应材 reported revenue of ¥1.55B for the period ended 2026-06-30, +9.7% year on year. Net income was ¥0.10B, a 6.4% net margin on a 23.4% gross margin. Free cash flow for the period was ¥-0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.55B | +9.7% |
| Gross profit | ¥0.36B | — |
| Operating income | ¥0.11B | — |
| Net income | ¥0.10B | -8.6% |
| Gross margin | 23.4% | Net margin 6.4% |
| Revenue Q/Q | +1.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.18B | 76.6% |
| R&D | ¥0.05B | 3.6% |
| SG&A | ¥0.16B | 10.1% |
| Tax & other | ¥0.02B | 1.1% |
| Item | Amount |
|---|---|
| Total assets | ¥6.09B |
| Total liabilities | ¥3.90B |
| Shareholders' equity | ¥2.19B |
| Equity / assets | 36.0% |
| Operating cash flow | ¥0.10B |
| Capital expenditure | ¥0.12B |
| Free cash flow | ¥-0.02B |
| Cash conversion (OCF / net income) | 86% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
雅本化学 ・ 隆华科技 ・ 佳创视讯 ・ 通光线缆 ・ 兴源环境 ・ 尔康制药 ・ 佳沃食品 ・ 联建光电 ・ 中威电子 ・ 华宇软件 ・ 开能健康 ・ 梅安森
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies